Seattle's InBios: First to Receive FDA Authorization for Zika Test

First Diagnostic Test for Zika Gets FDA's OK to Market

InBios Receives FDA Market Authorization for its ZIKV Detect 2.0 IgM Capture ELISA for a Presumptive Diagnosis of Zika Virus Infection

FDA Grants Marketing Authorization for First Diagnostic Test for Detecting Zika IgM Antibodies to InBios

InBios announces FDA clearance of its Dengue NS1 ELISA kit

InBios announces FDA emergency use authorization for its Zika ELISA

As Zika Virus Spreads, Gaps In Diagnostic Testing Present Opportunities For Drug Companies

UTMB researchers help discover simple, affordable diagnostic kit for chikungunya

Leishmania Rapid Diagnostic Device Receives FDA Clearance

FDA Clearance: CL Detect™ Rapid Test Read US Army Medical Research and Material Command Press Release...